Coverage has been limited to other indications, such as: Diabetes Heart disease Sleep apnea That is starting to change under a new CMS program called the BALANCE model, which will allow Medicare Part D plans to offer coverage for obesity medications with standardized criteria and negotiated prices
Ye Y, Ma Y, Zhu J (2022) The future of dry powder inhaled therapy: promising or discouraging for systemic disorders
When home care alone isn't sufficient, professional underarm pigmentation treatments offer a more targeted solution
Notably, this comes as the FDA introduced a so-called Green List in September 2025: a mechanism aimed at preventing potentially unsafe active pharmaceutical ingredients (APIs) from unverified foreign sources, particularly those for GLP-1 drugs, from entering the U.S
But even if the price plummets, not everyone may be as eager to switch to a pill as I am